"Consistent with previous clinical studies, BTX 1503 was very well-tolerated. Adverse events were low across all treatment groups with the most commonly reported adverse event being upper respiratory tract infection (2.2% - 6.5%). Adverse events commonly seen with the use of topical acne products, application site stinging/ burning, itching (pruritus), pain, dryness, peeling and erythema were either absent or only observed in one or two patients. There were no severe adverse events reported and no treatment related discontinuations in the 5% BTX 1503 QD group. The very low incidence of application site adverse events supports the positioning of the Permetrex delivery technology as a safe and cosmetically elegant new formulation option for patients."
amateur apothecary thread -> LINK
- Forums
- ASX - By Stock
- BOT
- BOT: Moving Forward
BOT: Moving Forward, page-86
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
36.0¢ | 37.5¢ | 35.5¢ | $1.465M | 4.001M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 186321 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 561591 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 186321 | 0.360 |
1 | 76385 | 0.355 |
3 | 79000 | 0.350 |
3 | 610000 | 0.345 |
5 | 53979 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 561591 | 7 |
0.380 | 558186 | 12 |
0.385 | 145526 | 6 |
0.390 | 330104 | 16 |
0.395 | 345620 | 8 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |